Clinical Trial

Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A Phase I, Randomized, Double-blinded, Placebo-Controlled First-in-human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of J4 Dry Powder Capsule after Oral Administration of Single and Multiple Ascending Doses to Healthy Adults
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-14; most recent amendment 2026-01-01.
Trial Details
NCT Number NCT06938763
Lead Sponsor Academia Sinica, Taiwan
Conditions Alzheimer Disease
Enrollment 76 participants
Start Date 2025-02-14
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-06